Recruiting
Epileptic encephalopathy
RecruitingInvestigationalNo placebo
Study of Elsunersen in Children with SCN2A Developmental and Epileptic Encephalopathy to Reduce Seizures
InvestigationalNo placebo
- Disease:Epileptic encephalopathy
- Substances:5'-MOEMC-(SP)-MOEMC-(P)-MOEA-(P)-MOEMC-(P)-MOEG-(P)-MOEA-(P)-DMC-(SP)-DA-(SP)-DT-(SP)-DA-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DMC-(SP)-MOET-(P)-MOEA-(SP)-MOEMC-(SP)-MOEA 3'
Countries:
Germany
Germany- Participants:0–17 years · 18–64 years
- Substances:5'-MOEMC-(SP)-MOEMC-(P)-MOEA-(P)-MOEMC-(P)-MOEG-(P)-MOEA-(P)-DMC-(SP)-DA-(SP)-DT-(SP)-DA-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DT-(SP)-DMC-(SP)-MOET-(P)-MOEA-(SP)-MOEMC-(SP)-MOEA 3'
- Sponsor:Praxis Precision Medicines Inc.







